Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

337 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Alternative dosing regimen of exemestane in a randomized presurgical trial: the role of obesity in biomarker modulation.
Johansson H, Guerrieri-Gonzaga A, Gandini S, Bertelsen BE, Macis D, Serrano D, Mellgren G, Lazzeroni M, Thomas PS, Crew KD, Kumar NB, Briata IM, Galimberti V, Viale G, Vornik LA, Aristarco V, Buttiron Webber T, Spinaci S, Brown PH, Heckman-Stoddard BM, Szabo E, Bonanni B, DeCensi A. Johansson H, et al. Among authors: thomas ps. NPJ Breast Cancer. 2024 Jan 18;10(1):7. doi: 10.1038/s41523-024-00616-8. NPJ Breast Cancer. 2024. PMID: 38238336 Free PMC article.
Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer.
Thomas PS, Patel AB, Lee JJ, Liu DD, Hernandez M, Muzzio M, Contreras A, Sepeda V, Mays C, Weber D, Vornik LA, Khan SA, Dimond E, Heckman-Stoddard BM, Perloff M, Brown PH. Thomas PS, et al. Cancer Prev Res (Phila). 2023 Jan 4;16(1):47-55. doi: 10.1158/1940-6207.CAPR-22-0210. Cancer Prev Res (Phila). 2023. PMID: 36228112 Free PMC article. Clinical Trial.
Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative schedules.
Serrano D, Johansson H, Bertelsen BE, Gandini S, Mellgren G, Thomas P, Crew KD, Kumar NB, Macis D, Aristarco V, Guerrieri-Gonzaga A, Lazzeroni M, D'Amico M, Buttiron-Webber T, Briata IM, Spinaci S, Galimberti V, Vornik LA, Villar-Sanchez E, Brown PH, Heckman-Stoddard BM, Szabo E, Bonanni B, Decensi A. Serrano D, et al. J Natl Cancer Inst. 2024 Aug 7:djae183. doi: 10.1093/jnci/djae183. Online ahead of print. J Natl Cancer Inst. 2024. PMID: 39110531
Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic.
Bojadzieva J, Amini B, Day SF, Jackson TL, Thomas PS, Willis BJ, Throckmorton WR, Daw NC, Bevers TB, Strong LC. Bojadzieva J, et al. Among authors: thomas ps. Fam Cancer. 2018 Apr;17(2):287-294. doi: 10.1007/s10689-017-0034-6. Fam Cancer. 2018. PMID: 28988289
Trends in smoking initiation and cessation over a century in two Australian cohorts.
James AL, Caliskan G, Pesce G, Accordini S, Abramson MJ, Bui D, Musk AW, Knuiman MW, Perret JL, Jarvis D, Minelli C, Calciano L, Hui J, Hunter M, Thomas PS, Walters EH, Garcia-Aymerich J, Dharmage SC, Marcon A. James AL, et al. Among authors: thomas ps. PLoS One. 2024 Sep 19;19(9):e0307386. doi: 10.1371/journal.pone.0307386. eCollection 2024. PLoS One. 2024. PMID: 39298431 Free PMC article.
337 results